Gupta, M., Gupta, S., Graham, C. (2025). A post-marketing pharmacovigilance analysis of cardiotoxicities following chimeric antigen receptor T-cell therapy using the FDA adverse event reporting system. Blood. https://doi.org/10.1182/blood-2025-6301